Marker Therapeutics Inc (MRKR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -5,229 | -2,196 | -3,891 | N/A |
| Depreciation Amortization | 4 | 8 | 6 | N/A |
| Other Working Capital | 693 | 485 | 338 | N/A |
| Other Operating Activity | 3,410 | 989 | 2,298 | 0 |
| Operating Cash Flow | $-1,122 | $-714 | $-1,249 | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | N/A | N/A | -22 | N/A |
| Investing Cash Flow | $N/A | $N/A | $-22 | $N/A |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | 485 | 122 | 583 | N/A |
| Common Stock Issued | 700 | 60 | 458 | N/A |
| Other Financing Activity | 77 | 366 | 278 | 0 |
| Financing Cash Flow | $1,262 | $548 | $1,318 | $N/A |
| Beginning Cash Position | 1 | 168 | 120 | N/A |
| End Cash Position | 141 | 1 | 168 | N/A |
| Net Cash Flow | $140 | $-167 | $47 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -1,122 | -714 | -1,249 | N/A |
| Capital Expenditure | N/A | N/A | -22 | N/A |
| Free Cash Flow | -1,122 | -714 | -1,271 | 0 |